Skip to main content
Article thumbnail
Location of Repository

Calcium channel blockers: pharmacology and place in therapy of pediatric hypertension

By Deborah A. Pasko and Joseph T. Flynn

Abstract

The calcium channel blockers (CCBs) are a diverse group of antihypertensive medications with variable pharmacokinetics and clinical effects. Although CCBs have been widely applied to the treatment of hypertensive children, data regarding the pharmacokinetics, efficacy and safety of these agents in children are extremely limited. In this review we briefly summarize the mechanism of action of CCBs and then summarize pertinent pharmacokinetic information on each of the CCBs commonly used in children, including amlodipine, diltiazem, felodipine, isradipine, intravenous nicardipine, nifedipine and verapamil. Clinically important drug interactions and adverse effects are discussed, as well as the potential role of CCBs in renal protection. Available pediatric efficacy and safety data are summarized, and recommendations made regarding the rational use of CCBs in the management of pediatric hypertension

Publisher: Springer-Verlag; IPNA - International Pediatric Nephrology Association New York, USA
Year: 2000
DOI identifier: 10.1007/s004670000480
OAI identifier: oai:deepblue.lib.umich.edu:2027.42/42303
Journal:
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://hdl.handle.net/2027.42/... (external link)
  • http://dx.doi.org/10.1007/s004... (external link)
  • http://www.ncbi.nlm.nih.gov/si... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.